Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This randomized phase I trial is studying the side effects and best dose of
Se-methyl-seleno-L-cysteine in healthy adult men. Studying samples of blood, urine, and
toenail clippings in the laboratory from healthy men receiving Se-methyl-seleno-L-cysteine
may help doctors learn more about how Se-methyl-seleno-L-cysteine works in the body.